Partner Steve Hilfinger is quoted in an article in the Legal Executive Institute, “Automotive Industry Forum Preview: As the Auto Industry Transforms, It Grapples with Issues of Cybersecurity, IP & Connectivity,” about an upcoming summit he is co-chairing on the influential forces shaping commerce and compliance in the American automotive industry.
Hilfinger will moderate a panel that includes partners Pavan Agarwal and Christopher Swift that will examine several industry trends, such as the global M&A environment and industry-wide joint ventures.
“All these players have sort of common goals right now,” Hilfinger said. “They want to acquire technology, they want to acquire talent, and they want to be part of the group that sets the industry standards that will be commercially adopted.”
Hilfinger will moderate a panel that includes partners Pavan Agarwal and Christopher Swift that will examine several industry trends, such as the global M&A environment and industry-wide joint ventures.
“All these players have sort of common goals right now,” Hilfinger said. “They want to acquire technology, they want to acquire talent, and they want to be part of the group that sets the industry standards that will be commercially adopted.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”